Zaleplon controlled release - Intec Pharma

Drug Profile

Zaleplon controlled release - Intec Pharma

Alternative Names: Accordion Pill Zaleplon; AP-ZP; Gastric retentive dual release zaleplon AP; The Accordion Pill - Zaleplon; Zaleplon AP; Zaleplon GR

Latest Information Update: 25 Oct 2015

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Intec Pharma
  • Class Acetamides; Hypnosedatives; Pyrimidines; Sleep disorder therapies; Small molecules
  • Mechanism of Action GABA A receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase II Insomnia

Most Recent Events

  • 22 Oct 2015 Intec Pharma has patent protection for Accordion Pill platform in Europe
  • 07 Aug 2015 Phase II development is ongoing in USA and Israel
  • 06 Jun 2012 Intec Pharma completes phase-II trials in Insomnia
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top